BeStock  
Stocks › ARWR

Arrowhead Pharmaceuticals ARWR

US equityMarket cap rank #1888
$41.37 −$2.28 (-5.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $41.40 +0.07%
Open$43.15
Prev close$43.65
Day range$41.17 – $44.80
Volume3.91M
Market cap$5.85B
P/E (TTM)–
Dividend yield–

ARWR Stock News

Headlines matching Arrowhead Pharmaceuticals or the ARWR ticker, most recent first.

  • Citi Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $108Market news · 9 Sep 2026 · Direct mention
  • Citi Initiates Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Announces Target Price $108Market news · 8 Sep 2026 · Direct mention
  • Goldman Sachs Maintains Arrowhead Pharmaceuticals(ARWR.US) With Hold Rating, Cuts Target Price to $74 NegativeMarket news · 24 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $120Market news · 22 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy RatingMarket news · 16 Sep 2026 · Direct mention
  • Citi Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy RatingMarket news · 16 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $120Market news · 1 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $100 PositiveMarket news · 7 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $120 PositiveMarket news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Arrowhead Pharmaceuticals(ARWR.US), With a Forecast Between $89.59 to $126Market news · 5 Aug 2026 · Direct mention
  • B. Riley Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $123Market news · 5 Aug 2026 · Direct mention
  • RBC Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $100Market news · 31 Aug 2026 · Direct mention
  • Analysts Are Bullish on Top Healthcare Stocks: CapsoVision, Inc. (CV), Arrowhead Pharmaceuticals (ARWR) PositiveTipRanks · 31 Aug 2026 · Direct mention
  • TD Cowen Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy RatingMarket news · 31 Aug 2026 · Direct mention
  • Stifel Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $104Market news · 31 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ARWR.

Sign in to join the discussion.

Scroll to Top